Orencia 125 mg (Abatacept SOLUTION) 125 MG

Orencia 125 mg subcutaneous solution is a medication used to manage certain autoimmune conditions. This solution is designed for subcutaneous administration and is manufactured by Bristol-Myers Squibb Canada.

Strength

125 MG

Pack Size

1/4

Manufacturer / TM Owner

BRISTOL-MYERS SQUIBB CANADA

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Orencia 125 mg is primarily used for the treatment of moderate to severe rheumatoid arthritis in adults. It is often prescribed for patients who have not responded well to other treatments. The medication works by modulating the immune system to reduce inflammation and slow the progression of joint damage. Orencia is also used in combination with other drugs to manage symptoms effectively.

Side Effects

Common effects of Orencia 125 mg may include redness, swelling, or itching at the injection site. Some users may experience headaches, nausea, or fatigue. These effects are generally mild and temporary. Serious side effects are rare but can include signs of infection or allergic reactions, which should be reported to a healthcare provider immediately.

Precautions & Warnings

Orencia 125 mg should be handled with care, ensuring proper storage and administration techniques. It is important to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Patients should inform their healthcare provider about any existing medical conditions or allergies before starting treatment. Regular monitoring may be required to assess the effectiveness and safety of the medication.

Avoid Interactions

Orencia 125 mg may interact with other medications, including immunosuppressants and biologics. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol consumption should be moderated, as it may affect the body's response to the medication. Always consult a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

Orencia 125 mg is used to manage moderate to severe rheumatoid arthritis in adults, particularly when other treatments have been ineffective.

Orencia 125 mg is administered subcutaneously, typically by injection. A healthcare professional will provide detailed instructions on proper administration.

Common side effects may include redness, swelling, or itching at the injection site, as well as headaches, nausea, or fatigue.

Orencia 125 mg may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Orencia 125 mg should be stored according to the manufacturer's guidelines, typically in a cool, dry place away from direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.